# US Urology Devices Market > US Urology Devices Market Research Report By Device Type (Surgical Instruments, Diagnostic Devices, Consumables, Therapeutic Devices), By Application (Urological Surgery, Urinary Incontinence, Benign Prostatic Hyperplasia, Kidney Stones), By End User (Hospitals, Clinics, Ambulatory Surgical Centers) and By Gender (Male, Female) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 19.99% - **2024:** $ 11.37 Billion - **2025:** $ 13.89 Billion - **2035:** $ 84.39 Billion - **Key Players:** Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), Baxter International (US), Coloplast (DK), Teleflex (US), Cook Medical (US), Stryker (US), UroGen Pharma (US) **Report ID:** MRFR/MED/14858-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-urology-devices-market-16386 --- ## Market Summary ## **US Urology Devices Market Overview** As per MRFR analysis, the US Urology Devices Market Size was estimated at 7.97 (USD Billion) in 2023. The US Urology Devices Market Industry is expected to grow from 9.75(USD Billion) in 2024 to 88.39 (USD Billion) by 2035. The US Urology Devices Market CAGR (growth rate) is expected to be around 22.19% during the forecast period (2025 - 2035). ### **Key US Urology Devices Market Trends Highlighted** The US Urology Devices Market is witnessing significant trends driven by a combination of technological advancements and increasing awareness of urological health. The rise in minimally invasive surgical techniques is one of the key market drivers, as many patients and healthcare providers prefer procedures that result in quicker recoveries and reduced complications. Moreover, advancements in robotics and imaging technologies are enabling more precise diagnoses and treatments, addressing a growing demand for improved patient outcomes. The increasing prevalence of urological disorders, including kidney stones and urinary incontinence, is fueling the market as more patients seek effective and innovative treatment options. Opportunities in the US market are primarily linked to the development of smart urology devices that integrate digital health features, allowing for remote patient monitoring and management of urological conditions. This not only enhances patient engagement but also aligns with the broader trend toward telemedicine, which has gained significant traction in recent years. Additionally, the aging population in the US is expected to increase the demand for urology devices, as older adults are more susceptible to urological issues. In recent times, there has also been a noticeable trend towards personalized medicine in urology, with patients receiving tailored treatment plans based on genetic or biomarker information. This shift is transforming the way conditions are diagnosed and treated in the US. Investment in research and development remains strong, as companies strive to innovate and improve existing urology devices. Overall, these trends highlight a dynamic and rapidly evolving landscape in the US Urology Devices Market, characterized by technological innovation, increased patient demand, and a focus on comprehensive care solutions. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **US Urology Devices Market Drivers** ### **Increasing Incidence of Urological Disorders** The incidence of urological disorders in the United States is on the rise, significantly driving the growth of the US Urology Devices Market Industry. According to the National Kidney Foundation, chronic kidney disease affects approximately 37 million adults in the United States. This increasing prevalence of conditions such as urinary incontinence, benign prostatic hyperplasia, and kidney stones points towards the necessity for advanced urology devices for effective management and treatment. Organizations such as the American Urological Association are actively focusing on research and public awareness campaigns, which adds to the demand for innovative devices that can offer improved patient outcomes, thus revitalizing the US Urology Devices Market. The significant rise in urological conditions necessitates a parallel increase in the availability and development of diagnostic and therapeutic devices catering to these diseases. ### **Technological Advancements in Urology Devices** Continuous technological advancements are playing a pivotal role in the growth of the US Urology Devices Market Industry. Innovations such as robotic-assisted surgeries and minimally invasive techniques have shown a marked improvement in surgical outcomes. According to the U.S. Food and Drug Administration, the number of new urological devices approved has been increasing annually, highlighting the dynamic nature of this sector. Research and Development expenditures by manufacturers and firms like Medtronic and Boston Scientific focus on developing precise and efficient devices. These advancements not only improve the effectiveness of treatments but also enhance patient recovery times, contributing to increased satisfaction and the demand for state-of-the-art urological solutions. ### **Aging Population in the United States** The aging population in the United States is a significant driver affecting the US Urology Devices Market Industry. According to the U.S. Census Bureau, it is projected that by 2034, there will be approximately 77 million older adults aged 65 and over. The incidence of urological disorders, including prostate issues and urinary tract infections, tends to be higher in older adults, leading to an increased need for urological care and devices. This demographic trend drives demand for specialized urology devices, prompting manufacturers to focus on developing products tailored to the needs of elderly patients. The growing elderly population represents a critical opportunity for the Urology Devices Market, spurring investments in advanced technologies and products designed to cater to this demographic. ## **US Urology Devices Market Segment Insights** ### **Urology Devices Market Device Type Insights** The US Urology Devices Market showcases a diverse range of device types that significantly contribute to the healthcare landscape. Surgical Instruments occupy a pivotal role, involving tools essential for various urological procedures and driving innovation in minimally invasive techniques, which is transforming patient outcomes. Diagnostic Devices are crucial in early detection and disease monitoring, enabling healthcare professionals to provide timely interventions and personalized treatment plans. The rising prevalence of urological disorders among the aging population further emphasizes their importance in maintaining health standards across the nation. Consumables represent another vital element, as they encompass various single-use products, ensuring hygienic conditions in procedures and aiding efficiency in urology departments. This category accounts for a majority holding of the overall market due to the consistent need for these products in everyday medical practice. Additionally, Therapeutic Devices are growing in prominence, as they encompass technologies aimed at treating urological conditions, enhancing the quality of life for many patients through innovative therapies. The dynamic US Urology Devices Market segmentation reflects the surging demand supported by factors such as technological advancements, an increase in the aging population, and higher healthcare expenditure. Strengthening the market further are trends like the rising adoption of robotic-assisted surgeries and telehealth solutions, which continue to reshape the landscape of urological treatments. Amid these opportunities, the market also faces challenges including regulatory hurdles and the need for consistent quality assurance. All these factors collectively underline the significance of the Device Type segment within the US Urology Devices Market and its potential for extensive growth in the coming years. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Urology Devices Market Application Insights** The US Urology Devices Market encompasses various applications, prominently including Urological Surgery, Urinary Incontinence, Benign Prostatic Hyperplasia, and Kidney Stones. Urological Surgery is essential for managing various urological conditions, driving significant demand for innovative surgical devices and techniques. Urinary Incontinence represents a major concern, particularly among aging populations, highlighting the need for effective treatment solutions and advanced devices that enhance patient quality of life. Benign Prostatic Hyperplasia remains prevalent, necessitating the development of minimally invasive devices that cater to an increasing number of patients seeking relief. Additionally, the rising incidence of Kidney Stones underscores the importance of specialized devices for diagnosis, treatment, and management, as these conditions often require surgical intervention and ongoing care. Overall, the segmentation of applications within the US Urology Devices Market highlights the diversity of needs and the growing importance of technological advancements to address both common and complex urological issues faced by the population. The market growth is supported by increasing awareness and improved healthcare access, alongside demographic trends indicating an aging population susceptible to urological conditions. ### **Urology Devices Market End User Insights** The US Urology Devices Market is experiencing significant growth, driven by increased prevalence of urological conditions and advancements in technology. Among the End User segment, hospitals play a crucial role by providing comprehensive urological care and housing advanced urology devices. Clinics also contribute significantly, as they often serve as the first point of consultation for patients and have begun incorporating innovative devices for outpatient procedures, thus enhancing patient accessibility and treatment options. Furthermore, Ambulatory Surgical Centers are gaining traction due to the shifting preference towards outpatient surgeries, which offer faster recovery times and lower costs compared to traditional hospital admissions. The combination of technological advancements and the increasing demand for urology services is leading to improved patient outcomes and efficiency within these settings. As urological diseases continue to rise in the US, the importance of these End Users in the healthcare landscape cannot be overstated, supporting overall growth in the US Urology Devices Market. ### **Urology Devices Market Gender Insights** The US Urology Devices Market is intrinsically linked to gender, reflecting distinct medical needs and treatment approaches for both males and females. The market has shown substantial growth as advancements in technology and increasing awareness of urological health improve treatment options. Male-specific devices often focus on conditions such as benign prostatic hyperplasia and erectile dysfunction, representing a significant portion of procedures within the urology sector. Conversely, female urology devices address issues like urinary incontinence and pelvic floor disorders, which are gaining recognition due to growing advocacy and research emphasizing women's health. The rising prevalence of these conditions, combined with an aging population, drives the demand within the market. Moreover, trends toward enhanced minimally invasive surgical techniques and more effective therapeutic devices further propel market growth. The US government has also acknowledged the importance of urological health by supporting Research and Development initiatives, which foster innovation within this gender-focused segment. Increasing investment in healthcare infrastructure and education around urological issues are pivotal in shaping the future landscape of the US Urology Devices Market, leading to improved outcomes for both men and women. ## **US Urology Devices Market Key Players and Competitive Insights** The US Urology Devices Market is characterized by a complex competitive landscape, driven by advancements in technology, increased demand for minimally invasive procedures, and an aging population. Several key players dominate this market, competing on factors such as product innovation, quality, pricing, and customer service. The market is significantly influenced by the rising prevalence of urological conditions, leading to an increase in the utilization of urology devices. Companies are focusing on expanding their product portfolios and enhancing their market presence through strategic partnerships, mergers, and the adoption of cutting-edge technologies aimed at improving patient outcomes. Additionally, regulatory changes and an emphasis on cost-effective solutions further shape the competitive dynamics within this sector. Teleflex has established a significant footprint in the US Urology Devices Market through its innovative product offerings and a strong commitment to advancing healthcare solutions. The company's strengths lie in its comprehensive range of urology products, which includes catheters, drainage systems, and endoscopic devices that cater to various urological procedures. Teleflex's focus on research and development enables it to stay ahead of the competition by continually introducing new products that meet the evolving needs of healthcare providers and patients. Moreover, the company's strong distribution network and strategic collaborations enhance its market reach, ensuring that its advanced urology solutions are widely available across the United States. This significant market presence, combined with a reputation for high-quality products, reinforces Teleflex's competitive advantage within the urology devices sector. Acelity operates in the US Urology Devices Market with a focus on advanced wound care and related products that indirectly support urological health. The company is known for its innovative solutions such as negative pressure wound therapy that can aid in postoperative recovery for urological surgeries. Acelity's strengths lie in its robust research and development capabilities, allowing it to introduce cutting-edge technologies that enhance therapeutic outcomes. The company’s market presence has been bolstered through strategic mergers and acquisitions, which have expanded its product capabilities and distribution channels within the US. Its commitment to quality and improvement in patient care positions Acelity favorably in the competitive landscape of the US Urology Devices Market. The combination of its extensive product range and a strong operational framework supports Acelity in maintaining a solid market presence while catering to the evolving needs of healthcare professionals in urology. ### **Key Companies in the US Urology Devices Market Include** ## **US Urology Devices Market Industry Developments** Recent developments in the US Urology Devices Market indicate a growing trend in technological advancements and strategic mergers. Companies like Teleflex and Medtronic are focusing on innovative solutions to enhance patient outcomes and increase market penetration. There has been significant growth in the market valuation of key players, with Boston Scientific experiencing notable increases in share prices driven by their comprehensive product portfolio and successful launch of advanced urology products over the past two years. In March 2023, Stryker Corporation announced the acquisition of a urology device technology company aiming to expand its offerings in robotic-assisted surgery. Additionally, advancements in minimally invasive techniques for urological procedures have surged, reflecting changing preferences among healthcare providers. The continuous rise in the aging population and increasing prevalence of urological conditions have further fueled demand for urology devices. Companies like Johnson and Johnson and Coloplast are investing heavily in Research and Development to stay competitive in this dynamic environment. This activity in the market signifies a robust and rapidly evolving landscape in the US Urology Devices Market. ## **US Urology Devices Market Segmentation Insights** ### **Urology Devices Market Device Type Outlook** ### **Urology Devices Market Application Outlook** ### **Urology Devices Market End User Outlook** ### **Urology Devices Market Gender Outlook** ## Market Drivers ### Growing Awareness and Education The US [Urology Devices](https://www.marketresearchfuture.com/reports/urology-devices-market-1120) Market is bolstered by increasing awareness and education regarding urological health. Campaigns aimed at destigmatizing urological disorders have led to more individuals seeking medical advice and treatment. Organizations such as the American Urological Association provide resources and information, empowering patients to understand their conditions better. This heightened awareness translates into a greater demand for urology devices, as patients are more likely to pursue treatment options. Moreover, educational initiatives targeting healthcare professionals ensure that they are well-informed about the latest advancements in urology devices, further driving market growth as they recommend these solutions to their patients. ### Government Initiatives and Funding The US Urology Devices Market benefits from various government initiatives aimed at improving healthcare access and quality. Federal programs, such as the National Institutes of Health funding for urological research, play a crucial role in advancing the development of new devices and treatment modalities. Additionally, policies promoting preventive care and early diagnosis contribute to increased awareness and utilization of urology devices. The Centers for Medicare & Medicaid Services also support reimbursement for innovative urological treatments, further incentivizing healthcare providers to adopt advanced technologies. This supportive regulatory environment fosters growth in the urology devices market, encouraging investment and innovation. ### Rising Prevalence of Urological Disorders The US Urology Devices Market is experiencing growth due to the increasing prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and kidney stones. According to the National Institute of Diabetes and Digestive and Kidney Diseases, millions of Americans are affected by these conditions, leading to a heightened demand for effective treatment options. This surge in patient numbers necessitates the development and adoption of advanced urology devices, which are essential for diagnosis and management. As healthcare providers seek to improve patient outcomes, the market is likely to expand, driven by the need for innovative solutions that address these prevalent health issues. ### Technological Innovations in Urology Devices The US Urology Devices Market is significantly influenced by rapid technological advancements. Innovations such as minimally invasive surgical techniques, robotic-assisted surgeries, and advanced imaging technologies are transforming the landscape of urological care. For instance, the introduction of laser lithotripsy devices has revolutionized the treatment of kidney stones, offering patients quicker recovery times and reduced complications. Furthermore, the integration of artificial intelligence in diagnostic tools enhances accuracy and efficiency in identifying urological conditions. These technological breakthroughs not only improve patient care but also stimulate market growth as healthcare facilities invest in state-of-the-art urology devices to remain competitive. ### Aging Population and Increased Healthcare Demand The US Urology Devices Market is significantly impacted by the aging population, which is more susceptible to urological disorders. As the baby boomer generation continues to age, the demand for urology devices is expected to rise sharply. According to the U.S. Census Bureau, the number of individuals aged 65 and older is projected to double by 2060, leading to an increased prevalence of conditions such as prostate cancer and urinary incontinence. This demographic shift necessitates the development and availability of specialized urology devices to cater to the unique needs of older adults. Consequently, manufacturers are likely to focus on creating innovative solutions that address the challenges faced by this growing population. ## Future Outlook The US Urology Devices Market is projected to grow at a 19.99% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of urological disorders, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for early detection of urological conditions. Expansion of telehealth services for remote patient monitoring and consultations. Investment in minimally invasive surgical devices to enhance patient recovery and reduce hospital stays. By 2035, the Urology Devices Market is expected to be robust, driven by innovation and increased demand. ## Segment Insights ### By Application: Urology Surgery (Largest) vs. Urological Monitoring (Fastest-Growing) The US Urology Devices Market exhibits a well-distributed market share across its various application segments, with Urology Surgery holding the largest share. Urology Surgery encompasses a range of surgical procedures and tools, making it a critical component of urological care. Other segments include Urological Diagnostics, Urological Treatment, and Urological Monitoring, each contributing significantly to the overall landscape, but falling behind in size as compared to surgery. Urology Surgery (Dominant) vs. Urological Monitoring (Emerging) Urology Surgery stands as the dominant player in the US Urology Devices Market, characterized by its extensive range of surgical instruments and devices designed for effective urological interventions. This segment benefits from continuous advancements in technology, improving surgical outcomes and patient safety. Conversely, Urological Monitoring is gaining traction as an emerging segment. The sector focuses on innovative devices that aid in the ongoing assessment of urological conditions, driven by a growing emphasis on preventive care and [chronic disease management](https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981), positioning it as a key growth area. ### By Device Type: Endoscopic Devices (Largest) vs. Surgical Instruments (Fastest-Growing) In the US Urology Devices Market, Endoscopic Devices hold the largest share, reflecting their widespread adoption in various urological procedures. Following them, Surgical Instruments are gaining traction, driven by increasing surgical interventions and advancements in technology. Catheters and stents also contribute to the market, albeit to a lesser extent, while Dialysis Equipment remains crucial for chronic patients, impacting the overall share distribution significantly. Growth trends in this segment are primarily influenced by technological advancements and rising incidences of urological conditions. The preference for minimally invasive procedures boosts the demand for Endoscopic Devices, whereas Surgical Instruments are experiencing rapid innovation, leading to their designation as the fastest-growing segment. Overall, patient safety and efficiency in treatments drive these dynamics in the urology devices market. Endoscopic Devices (Dominant) vs. Catheters (Emerging) Endoscopic Devices dominate the US Urology Devices Market due to their versatility and efficiency in diagnosis and treatment procedures. They facilitate minimally invasive surgeries, reducing recovery times for patients. This dominance is supported by continuous technological advancements and a growing preference for outpatient procedures. In contrast, Catheters, while emerging, play a crucial role in patient care, especially among those with chronic conditions requiring long-term management. The innovation in catheter materials and designs, aimed at enhancing comfort and reducing complications, positions them as an important growth area. Their growing application in homecare settings further signifies an emerging trend, catering to the preferences of both patients and healthcare providers. ### By End User: Hospitals (Largest) vs. Urology Clinics (Fastest-Growing) In the US Urology Devices Market, hospitals dominate the end user segment due to their advanced facilities and greater patient volume, capturing a substantial share. Ambulatory surgical centers also contribute significantly to the market, benefiting from the increasing preference for outpatient care and minimally invasive procedures. Urology clinics and research institutions, while smaller in comparison, hold critical roles in specialized care and innovation respectively, further diversifying the sector. Hospitals (Dominant) vs. Urology Clinics (Emerging) Hospitals are the dominant players in the US Urology Devices Market, known for their extensive resources, skilled personnel, and comprehensive urological services. They typically invest in the latest technologies, ensuring they offer cutting-edge treatments to cater to intricate urological issues. Urology clinics, emerging as pivotal entities within this domain, are gaining traction due to rising demands for personalized care and specialized treatments. They focus on specific urological disorders, allowing for tailored approaches that often result in quicker recovery times, positioning them as a preferred choice among patients seeking targeted solutions. ## Competitive Benchmarking The Urology Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of urological disorders, and a growing aging population. Major players such as Boston Scientific (US), Medtronic (US), and Johnson & Johnson (US) are strategically positioned to leverage innovation and expand their market presence. Boston Scientific (US) focuses on developing minimally invasive solutions, while Medtronic (US) emphasizes digital health integration and patient-centric technologies. Johnson & Johnson (US) is enhancing its portfolio through strategic acquisitions and partnerships, collectively shaping a competitive environment that prioritizes advanced therapeutic options and improved patient outcomes. The market structure appears moderately fragmented, with key players employing various business tactics to optimize their operations. Localizing manufacturing and enhancing supply chain efficiencies are common strategies among these companies, allowing them to respond swiftly to market demands. The collective influence of these major players fosters a competitive atmosphere where innovation and operational excellence are paramount, driving growth and market share. In December 2025, Boston Scientific (US) announced the launch of its latest urology device, which integrates AI technology to enhance diagnostic accuracy. This strategic move not only positions the company at the forefront of technological innovation but also addresses the increasing demand for precision in urological treatments. The integration of AI is likely to improve patient outcomes and streamline clinical workflows, reinforcing Boston Scientific's competitive edge. In November 2025, Medtronic (US) unveiled a new telehealth platform designed specifically for urology patients, enabling remote monitoring and consultations. This initiative reflects a growing trend towards digital health solutions, allowing Medtronic to enhance patient engagement and accessibility. By investing in telehealth, Medtronic is likely to strengthen its market position and cater to the evolving needs of healthcare providers and patients alike. In October 2025, Johnson & Johnson (US) completed the acquisition of a promising urology startup focused on innovative catheter technologies. This acquisition is indicative of Johnson & Johnson's commitment to expanding its product offerings and enhancing its technological capabilities. By integrating the startup's expertise, the company may accelerate its innovation pipeline and respond more effectively to market demands. As of January 2026, current competitive trends in the Urology Devices Market include a pronounced shift towards digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on innovation and technology rather than price-based competition. Companies that prioritize supply chain reliability and advanced technological solutions are likely to thrive in this rapidly changing environment. ## Recent News & Developments Recent developments in the US Urology Devices Market indicate a growing trend in technological advancements and strategic mergers. Companies like Teleflex and Medtronic are focusing on innovative solutions to enhance patient outcomes and increase market penetration. There has been significant growth in the market valuation of key players, with Boston Scientific experiencing notable increases in share prices driven by their comprehensive product portfolio and successful launch of advanced urology products over the past two years. In March 2023, Stryker Corporation announced the acquisition of a urology device technology company aiming to expand its offerings in robotic-assisted surgery. Additionally, advancements in minimally invasive techniques for urological procedures have surged, reflecting changing preferences among healthcare providers. The continuous rise in the aging population and increasing prevalence of urological conditions have further fueled demand for urology devices. Companies like Johnson and Johnson and Coloplast are investing heavily in Research and Development to stay competitive in this dynamic environment. This activity in the market signifies a robust and rapidly evolving landscape in the US Urology Devices Market. ## Report Scope | MARKET SIZE 2024 | 11.37(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 13.89(USD Billion) | | MARKET SIZE 2035 | 84.39(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 19.99% (2024 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), Baxter International (US), Coloplast (DK), Teleflex (US), Cook Medical (US), Stryker (US), UroGen Pharma (US) | | Segments Covered | Application, Device Type, End User | | Key Market Opportunities | Integration of advanced minimally invasive technologies enhances patient outcomes in the US Urology Devices Market. | | Key Market Dynamics | Technological advancements drive innovation in the US Urology Devices Market, enhancing patient outcomes and operational efficiency. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US Urology Devices Market?** A: The US Urology Devices Market was valued at 11.37 USD Billion in 2024. **Q: What is the projected market valuation for the US Urology Devices Market by 2035?** A: The market is projected to reach 84.39 USD Billion by 2035. **Q: What is the expected CAGR for the US Urology Devices Market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period is 19.99%. **Q: Which companies are considered key players in the US Urology Devices Market?** A: Key players include Boston Scientific, Medtronic, Johnson & Johnson, Baxter International, Coloplast, Teleflex, Cook Medical, Stryker, and UroGen Pharma. **Q: What are the main application segments in the US Urology Devices Market?** A: The main application segments include Urology Surgery, Urological Diagnostics, Urological Treatment, and Urological Monitoring. **Q: How did the Urological Treatment segment perform in 2024?** A: The Urological Treatment segment was valued at 4.54 USD Billion in 2024. **Q: What is the valuation of the Endoscopic Devices segment in the US Urology Devices Market?** A: The Endoscopic Devices segment was valued at 2.27 USD Billion in 2024. **Q: Which end-user segment had the highest valuation in 2024?** A: In 2024, the Hospitals segment had the highest valuation at 3.5 USD Billion. **Q: What is the projected growth for Urological Diagnostics by 2035?** A: The Urological Diagnostics segment is projected to grow to 25.56 USD Billion by 2035. **Q: What device type is expected to see significant growth in the US Urology Devices Market?** A: Surgical Instruments, valued at 2.84 USD Billion in 2024, are expected to see significant growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-urology-devices-market-16386*